Subcutaneous immunoglobulin in primary immunodeficiency – impact of training and infusion characteristics on patient-reported outcomes

Subcutaneous immunoglobulin (SCIG) is increasingly utilized in primary immunodeficiency (PI). Understanding factors associated with treatment experience and satisfaction can optimize patient outcomes. We analy...

Source: BMC Immunology - August 10, 2020 Category: Allergy & Immunology Authors: R. Mallick, T. Henderson, B. J. Lahue, A. Kafal, P. Bassett and C. Scalchunes Tags: Research article Source Type: research